NeuroConnection.net

Time to Complete Activity:

1.0 hour per segment

Designation Statement

Ciné-Med, Inc. designates this educational activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

How to get CME credit

To receive credit, participants must view the webcast or DVD, register on this site, and successfully complete the post-test and evaluation (successful passing grade >70%). Certificates can be printed on line.

Accreditation

This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Cine-Med Inc. and Astute Technology. Cine-Med, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

Target Audience

This activity is intended for neurologists and other medical professionals with a specific interest in the management of Parkinson's Disease.

Learning Objectives:

At the conclusion of this continuing medical education activity, participants should be able to:

• Differentiate the various treatment options available for initial treatment of Parkinson's Disease
• Identify the mechanisms of action of the medications available for the symptomatic treatment of both early and advanced Parkinson's Disease
• Discuss the pros and cons of levodopa
• Discuss the pros and cons of the ancillary treatment options for Parkinson's Disease

Disclosure statement

Cine-Med, In accordance with the ACCME's Standards for Commercial Support, requires individuals with control over content to disclose to learners any relevant financial relationships(s). Faculty disclosures can be found on the Faculty page.